Document is current
Any future updates will be listed below
-
Authors
Ballhausen, Alexej https://orcid.org/0000-0002-5470-4973
Ben Hamza, Amin
Welters, Carlotta
Dietze, Kerstin
Bullinger, Lars
Rahn, Hans-Peter
Hartmann, Sylvia
Hansmann, Martin-Leo
Hansmann, Leo https://orcid.org/0000-0003-3790-0128
-
Funding
Funding for this research was provided by:
Deutsche Krebshilfe (70113355)
Berliner Krebsgesellschaft (HAFF202013 MM)
- License Information
-
More Information
Article History
Received: 5 May 2022
Accepted: 23 July 2022
First Online: 10 August 2022
Change Date: 12 October 2022
Change Type: Update
Change Details: Missing Open Access funding information has been added in the Funding Note
Declarations
:
: Lars Bullinger: Advisory Committees: Abbvie, Amgen, Astellas, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Gilead, Hexal, Janssen, Jazz Pharmaceuticals, Menarini, Novartis, Pfizer, Sanofi, Seattle Genetics; Research support Bayer and Jazz Pharmaceuticals. All other authors have no relevant financial or non-financial interests to disclose.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Goethe-University Frankfurt am Main, Germany (<i>Ethik-Kommission der Goethe-Universität Frankfurt am Main</i>, project UCT -03–2016). Written informed consent was obtained from all patients.
